A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

Statin use linked to better survival but higher cardiac adverse events in advanced prostate cancer patients treated with ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...

Drugs already in use could be combined to form a two-pronged attack on advanced prostate cancer, a study suggests.

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by ...

Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

CNN — (CNN) — President Joe Biden’s diagnosis of metastatic prostate cancer has understandably raised concerns and questions: How long has he had cancer, how will he be treated, and what is his ...

A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.